Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Gregory Bailey. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Gregory Bailey har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Director 67.243
Director 1.620.071
US:BHVN / Biohaven Ltd. Director 0
US:MDVN / Medivation, Inc. Director 20.626
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Gregory Bailey. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Gregory Bailey som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-12-19 2024-12-17 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 3.866 67.243 6,10 4,59 17.745 308.639
2024-09-25 2024-09-24 4 BHVN Biohaven Ltd.
Common Shares
P - Purchase 5.000 1.620.071 0,31 44,19 220.966 71.596.122
2024-09-24 2024-09-20 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 1.137 63.377 1,83 6,03 6.851 381.903
2024-09-20 2024-09-19 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 11.679 62.240 23,10 6,11 71.384 380.423
2024-09-20 2024-09-18 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 2.709 50.561 5,66 6,23 16.873 314.919
2024-08-22 2024-08-20 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 1.776 47.582 3,88 8,25 14.652 392.552
2024-08-20 2024-08-19 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 6.400 45.806 16,24 7,93 50.760 363.301
2024-08-20 2024-08-16 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 6.400 39.406 19,39 7,31 46.780 288.030
2024-08-20 2024-08-15 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 6.400 33.006 24,05 6,65 42.577 219.576
2024-08-16 2024-08-14 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 6.400 26.606 31,67 7,07 45.228 188.022
2024-05-31 2024-05-30 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 5.205 20.206 34,70 9,50 49.448 191.957
2024-05-31 2024-05-29 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 1.173 15.001 8,48 9,50 11.144 142.510
2024-05-29 2024-05-28 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 9.019 13.828 187,54 9,50 85.680 131.366
2024-05-24 2024-05-23 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 2.371 4.809 97,25 9,50 22.524 45.686
2024-05-24 2024-05-21 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 916 2.438 60,18 9,50 8.702 23.161
2024-05-23 2024-05-21 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 1.422 1.522 1.422,00 9,50 13.509 14.459
2024-05-22 2024-05-20 4 SER Serina Therapeutics, Inc.
Common Stock
P - Purchase 100 100 9,00 900 900
2024-05-15 2024-05-13 4 BHVN Biohaven Ltd.
Common Shares
P - Purchase 15.000 1.615.071 0,94 34,19 512.877 55.222.185
2024-04-25 2024-04-24 4 BHVN Biohaven Ltd.
Common Shares
P - Purchase 25.503 1.600.071 1,62 39,18 999.169 62.688.382
2024-04-23 2024-04-22 4 BHVN Biohaven Ltd.
Common Shares
P - Purchase 48.780 1.574.568 3,20 41,00 1.999.980 64.557.288
2023-10-06 2023-10-04 4 BHVN Biohaven Ltd.
Common Shares
P - Purchase 17.817 1.525.788 1,18 22,57 402.094 34.433.984
2022-10-26 2022-10-25 4 BHVN Biohaven Ltd.
Common Shares
P - Purchase 200.000 1.507.971 15,29 10,50 2.100.000 15.833.696
2022-10-05 2022-10-03 4 BHVN Biohaven Ltd.
Common Shares
F - Taxes -11.975 1.307.971 -0,91 7,50 -89.812 9.809.782
2022-10-05 2022-10-03 4 BHVN Biohaven Ltd.
Common Shares
M - Exercise 9.000 1.319.946 0,69 3,06 27.540 4.039.035
2022-10-05 2022-10-03 4 BHVN Biohaven Ltd.
Common Shares
M - Exercise 9.000 1.310.946 0,69 2,33 20.970 3.054.504
2022-10-05 2022-10-03 4 BHVN Biohaven Ltd.
Common Shares
M - Exercise 5.998 1.301.946 0,46 3,56 21.353 4.634.928
2022-10-05 2022-10-03 4 BHVN Biohaven Ltd.
Common Shares
M - Exercise 4.119 1.295.948 0,32 4,84 19.936 6.272.388
2022-10-05 2022-10-03 4 BHVN Biohaven Ltd.
Common Shares
J - Other 1.291.829 1.291.829
2022-10-03 2022-10-03 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
D - Sale to Issuer -2.583.658 0 -100,00 148,50 -383.673.213
2022-09-30 3 BHVN Biohaven Ltd.
No Securities Owned
0
2022-08-22 2022-08-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Stock
P - Purchase 38.000 2.583.658 1,49 148,04 5.625.676 382.495.323
2022-04-29 2022-04-28 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
A - Award 8.239 8.239
2021-06-23 2021-06-21 4 AGE AgeX Therapeutics, Inc.
Option to Purchase Common Stock
A - Award 65.000 65.000
2021-05-07 2021-05-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
A - Award 11.996 11.996
2020-10-23 2020-10-23 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -212 2.545.658 -0,01 79,94 -16.948 203.508.556
2020-10-23 2020-10-23 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -10.191 2.545.870 -0,40 78,89 -803.918 200.831.210
2020-10-23 2020-10-22 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -3.100 2.556.061 -0,12 79,88 -247.632 204.181.476
2020-10-23 2020-10-22 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -21.466 2.559.161 -0,83 79,41 -1.704.720 203.235.515
2020-10-21 2020-10-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -4.554 2.580.627 -0,18 78,98 -359.655 203.806.824
2020-10-21 2020-10-16 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -3.748 2.585.181 -0,14 78,88 -295.638 203.916.234
2020-10-14 2020-10-12 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -6.729 2.588.929 -0,26 78,87 -530.740 204.198.150
2020-07-10 2020-07-08 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -5.991 2.595.658 -0,23 75,93 -454.888 197.084.678
2020-07-10 2020-07-08 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -44.009 2.601.649 -1,66 75,12 -3.305.877 195.431.190
2020-06-25 2020-06-24 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -2.395 2.645.658 -0,09 70,24 -168.225 185.831.018
2020-06-25 2020-06-24 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -1.600 2.648.053 -0,06 69,29 -110.865 183.485.181
2020-06-25 2020-06-23 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -835 2.649.653 -0,03 75,18 -62.779 199.213.631
2020-06-25 2020-06-23 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -63.257 2.650.488 -2,33 74,60 -4.719.257 197.738.332
2020-06-25 2020-06-23 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -24.084 2.713.745 -0,88 73,72 -1.775.369 200.045.612
2020-06-25 2020-06-23 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -13.467 2.737.829 -0,49 72,70 -979.027 199.035.240
2020-06-22 2020-06-22 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -49.132 2.751.296 -1,75 73,64 -3.618.012 202.601.586
2020-06-22 2020-06-22 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -20.659 2.800.428 -0,73 72,91 -1.506.202 204.173.045
2020-06-22 2020-06-22 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -10.540 2.821.087 -0,37 72,01 -758.961 203.139.986
2020-06-22 2020-06-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -428 2.831.627 -0,02 75,22 -32.193 212.989.886
2020-06-22 2020-06-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -22.584 2.832.055 -0,79 73,78 -1.666.268 208.951.567
2020-06-22 2020-06-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -12.157 2.854.639 -0,42 72,93 -886.619 208.190.821
2020-06-22 2020-06-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -21.798 2.866.796 -0,75 71,98 -1.568.935 206.340.796
2020-06-22 2020-06-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -58.238 2.888.594 -1,98 70,91 -4.129.855 204.840.022
2020-06-22 2020-06-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -26.814 2.946.832 -0,90 70,10 -1.879.793 206.587.363
2020-06-22 2020-06-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -22.012 2.973.646 -0,73 69,01 -1.519.094 205.217.555
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
M - Exercise -212.500 0 -100,00
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
M - Exercise -150.000 0 -100,00
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (right to buy)
M - Exercise -37.700 0 -100,00
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
M - Exercise -18.000 0 -100,00
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
F - Taxes -30.143 2.995.658 -1,00 68,15 -2.054.245 204.154.093
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
M - Exercise 18.000 3.025.801 0,60 28,76 517.680 87.022.037
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
M - Exercise 20.000 3.007.801 0,67 10,82 216.400 32.544.407
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
M - Exercise 37.700 2.987.801 1,28 9,29 350.233 27.756.671
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
M - Exercise 150.000 2.950.101 5,36 5,60 840.000 16.520.566
2020-06-08 2020-06-05 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
M - Exercise 212.500 2.800.101 8,21 0,61 129.625 1.708.062
2020-05-01 2020-04-30 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
A - Award 18.000 18.000
2019-08-21 2019-08-20 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
P - Purchase 5.000 2.587.601 0,19 37,65 188.250 97.423.178
2019-05-23 2019-05-21 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
A - Award 18.000 18.000
2019-04-05 2019-03-25 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Warrant to Purchase Common Shares (Right to Buy)
M - Exercise -107.500 0 -100,00
2019-04-05 2019-03-25 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
M - Exercise 107.500 2.582.601 4,34 9,29 998.675 23.992.363
2019-03-13 2019-03-11 4 AGE AgeX Therapeutics, Inc.
Option to Purchase Common Stock
A - Award 100.000 100.000
2018-11-27 3 AGE AgeX Therapeutics, Inc.
Common Stock
0
2018-05-03 2018-05-01 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
A - Award 18.000 18.000
2018-02-02 2018-01-31 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -23.320 2.475.101 -0,93 34,32 -800.342 84.945.466
2018-02-02 2018-01-31 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -18.280 2.498.421 -0,73 33,42 -610.918 83.497.230
2018-02-02 2018-01-31 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -8.400 2.516.701 -0,33 32,63 -274.092 82.119.954
2018-01-25 2018-01-23 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -16.000 2.525.101 -0,63 32,79 -524.640 82.798.062
2018-01-23 2018-01-22 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -9.000 2.541.101 -0,35 32,51 -292.590 82.611.194
2018-01-23 2018-01-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -15.939 2.550.101 -0,62 31,08 -495.384 79.257.139
2018-01-23 2018-01-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -17.249 2.566.040 -0,67 30,18 -520.575 77.443.087
2018-01-23 2018-01-19 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -6.812 2.583.289 -0,26 29,20 -198.910 75.432.039
2018-01-18 2018-01-16 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -40.000 2.590.101 -1,52 26,52 -1.060.800 68.689.479
2018-01-05 2018-01-04 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -16.976 1.170.299 -1,43 28,77 -488.400 33.669.502
2018-01-05 2018-01-03 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -33.024 1.187.275 -2,71 28,68 -947.128 34.051.047
2017-12-22 2017-12-20 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -13.778 1.220.299 -1,12 26,73 -368.286 32.618.592
2017-12-22 2017-12-20 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -25.652 1.234.077 -2,04 26,08 -669.004 32.184.728
2017-12-01 2017-11-30 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -3.030 1.259.729 -0,24 25,47 -77.174 32.085.298
2017-12-01 2017-11-29 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -6.940 1.262.759 -0,55 25,48 -176.831 32.175.099
2017-11-28 2017-11-27 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -20.000 1.269.699 -1,55 25,92 -518.400 32.910.598
2017-11-28 2017-11-24 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
S - Sale X -600 1.289.699 -0,05 26,02 -15.612 33.557.968
2017-05-09 2017-05-09 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Series A Preferred Shares
C - Conversion -1.076.299 0 -100,00
2017-05-09 2017-05-09 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
P - Purchase 175.000 1.290.299 15,69 17,00 2.975.000 21.935.083
2017-05-09 2017-05-09 4 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
C - Conversion 1.076.299 1.115.299 2.759,74
2017-05-03 3 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
78.000
2017-05-03 3 BHVN Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
78.000
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Stock Option (Right to Buy)
M - Exercise -9.374 20.626 -31,25
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Stock Option (Right to Buy)
M - Exercise -17.498 12.502 -58,33
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Stock Option (Right to Buy)
M - Exercise -24.999 5.001 -83,33
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Stock Option (Right to Buy)
M - Exercise -30.000 0 -100,00
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Stock Option (Right to Buy)
M - Exercise -60.000 0 -100,00
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Stock Option (Right to Buy)
M - Exercise -101.900 0 -100,00
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Common Stock
M - Exercise 9.374 691.101 1,38 11,00 103.114 7.602.111
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Common Stock
M - Exercise 17.498 681.727 2,63 4,42 77.341 3.013.233
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Common Stock
M - Exercise 24.999 664.229 3,91 11,20 280.114 7.442.686
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Common Stock
M - Exercise 30.000 639.230 4,92 6,96 208.950 4.452.237
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Common Stock
M - Exercise 60.000 609.230 10,92 9,38 562.500 5.711.531
2012-11-01 2012-10-30 4 MDVN MEDIVATION, INC.
Common Stock
M - Exercise 101.900 549.230 22,78 1,50 152.850 823.845
2012-10-26 2012-10-24 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -16.800 447.330 -3,62 53,60 -900.480 23.976.888
2012-10-18 2012-10-16 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -3.200 464.130 -0,68 53,50 -171.200 24.830.955
2012-10-09 2012-10-05 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -20.000 467.330 -4,10 58,42 -1.168.400 27.301.419
2012-10-09 2012-10-04 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -20.000 487.330 -3,94 57,77 -1.155.400 28.153.054
2012-10-03 2012-10-02 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -4.326 507.330 -0,85 56,75 -245.500 28.790.978
2012-10-03 2012-10-02 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -25.674 511.656 -4,78 56,33 -1.446.216 28.821.582
2012-09-27 2012-09-27 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -20.000 537.330 -3,59 56,84 -1.136.800 30.541.837
2012-09-27 2012-09-27 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -30.000 557.330 -5,11 55,78 -1.673.400 31.087.867
2012-09-27 2012-09-25 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale X -10.000 587.330 -1,67 54,78 -547.800 32.173.937
2012-09-10 2012-09-07 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -1.107 298.665 -0,37 108,95 -120.608 32.539.552
2012-09-10 2012-09-07 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -443 299.772 -0,15 105,70 -46.825 31.685.900
2012-09-10 2012-09-06 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -16.440 300.215 -5,19 108,46 -1.783.082 32.561.319
2012-09-10 2012-09-06 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -12.166 316.655 -3,70 107,95 -1.313.320 34.182.907
2012-07-17 2012-07-16 4 MDVN MEDIVATION, INC.
Director Stock Option (right to buy)
A - Award 7.500 7.500
2012-07-03 2012-07-03 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -2.000 328.821 -0,60 95,17 -190.340 31.293.895
2012-07-03 2012-07-02 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -5.500 330.821 -1,64 93,40 -513.700 30.898.681
2012-07-03 2012-06-29 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -1.000 336.321 -0,30 91,54 -91.540 30.786.824
2012-07-03 2012-06-29 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -2.000 337.321 -0,59 90,40 -180.800 30.493.818
2012-07-03 2012-06-29 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -6.500 339.321 -1,88 89,72 -583.180 30.443.880
2012-07-03 2012-06-29 4 MDVN MEDIVATION, INC.
Common Stock
S - Sale -1.500 345.821 -0,43 88,67 -133.005 30.663.948
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)